ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 716 filers reported holding ASTRAZENECA PLC in Q3 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,406,316 | -13.4% | 50,300 | -8.4% | 0.03% | -12.1% |
| Q2 2023 | $3,931,825 | -5.9% | 54,937 | -8.7% | 0.03% | -10.8% |
| Q1 2023 | $4,178,636 | +11.3% | 60,202 | +8.7% | 0.04% | +5.7% |
| Q4 2022 | $3,754,947 | +74998.9% | 55,383 | -34.1% | 0.04% | – |
| Q3 2022 | $5,000 | -99.9% | 84,094 | +61.6% | 0.00% | -100.0% |
| Q2 2022 | $3,438,000 | -10.9% | 52,040 | -10.5% | 0.06% | 0.0% |
| Q1 2022 | $3,857,000 | +6.5% | 58,147 | -6.5% | 0.06% | +5.8% |
| Q4 2021 | $3,622,000 | -8.0% | 62,174 | -5.1% | 0.05% | -17.5% |
| Q3 2021 | $3,935,000 | +14.3% | 65,510 | +14.0% | 0.06% | +14.5% |
| Q2 2021 | $3,442,000 | +47.5% | 57,463 | +22.4% | 0.06% | +19.6% |
| Q1 2021 | $2,334,000 | -4.0% | 46,949 | -3.5% | 0.05% | -4.2% |
| Q4 2020 | $2,432,000 | +600.9% | 48,642 | +669.2% | 0.05% | +71.4% |
| Q3 2020 | $347,000 | – | 6,324 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |